Paunovich Vukasin
Chief Technology Officer
Paunovich Vukasin has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Paunovich Vukasin is listed as Chief Technology Officer at LifeStance Health Group, Inc. Inside the rolling window, Paunovich Vukasin reported no open-market purchases and 2 open-market sales totaling $1.0M in LFST. The largest disclosed transaction in the window is a sale of 42,067 LFST shares on Sep 2, 2026, worth $541K.
Companies traded
Other insiders at LFST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Paunovich Vukasin made?
Paunovich Vukasin has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Paunovich Vukasin trade?
Paunovich Vukasin has filed SEC Form 4 disclosures for 1 company, including LFST.
When was Paunovich Vukasin's most recent SEC Form 4 filing?
Paunovich Vukasin's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Paunovich Vukasin's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Paunovich Vukasin is listed as Chief Technology Officer.
What is Paunovich Vukasin's total buy and sell value in the current window?
Inside the rolling retention window, Paunovich Vukasin bought $0 and sold $1.0M based on SEC Form 4 filings.
What was Paunovich Vukasin's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 42,067 LFST shares on 2026-09-02, worth $541K, per SEC Form 4 filings.